Uranium Royalty

Phase A — Understand the business

Lens 1 · Company Overview

Uranium Royalty Corp is a uranium-focused royalty, streaming and physical-holding company — it takes financial exposure to uranium without operating, developing or exploring anything itself. Three exposure legs:

1. Royalties & streams — 20 royalty interests across 18 properties (early-2024 count), overwhelmingly on non-producing / development-stage uranium projects. The 40-F's own risk factors state "a majority of the Company's assets are non-producing". The only two royalties on world-class producing mines are McArthur River and Cigar Lake (both Orano/Cameco-operated, Athabasca Basin, Saskatchewan).
2. Physical uranium — ~2,329,637 lbs U3O8 at Jan 31 2026, carried at C$184.9M. This is the largest single asset and the primary price-exposure lever. UROY elects to take its McArthur River royalty in-kind (physical uranium, 45-day notice), which is how it accretes pounds.
3. Equity/debt investments — ~C$57.97M of stakes in uranium companies (Jan 31 2026).

Corporate structure: Canadian company, HQ Vancouver BC; FY ends April 30; dual-listed Nasdaq: UROY and TSX: URC; CIK 1711570; foreign private issuer filing 40-F under the US–Canada MJDS; reports under IFRS; emerging-growth company (exempt from SOX 404(b) auditor attestation). 133,636,119 shares at Apr 30 2025 → ~146.48M by July 2026 (ATM dilution).

Contract structure & key terms:

• McArthur River — 1% gross-overriding-revenue royalty on a 9.063% share of production (via Orano's 30.195% interest); take-in-kind option. Cameco-disclosed life-of-mine cash costs C$15–16/lb (among the lowest globally) → the underlying mine is highly robust.
• Cigar Lake / Waterbury — 10–20% sliding-scale net profit interest on a 3.75% share of production (via Orano's 40.453% interest); NPI steps down to 10% after combined Cigar Lake + Dawn Lake production reaches 200M lbs U3O8.
• Roughrider — 1.9766% NSR; operator is UEC (a related party — see Lens 9/13).
• Reno Creek — 0.5% NPI capped at US$2.5M total.
• Anderson / Slick Rock / Workman Creek (US) — 1% NSR each.

The economic point: producing-royalty cash flow is tiny and lumpy (a McArthur River GORR on <0.1% of the mine's output); the value case rests on (a) mark-to-market on the physical uranium pile and (b) long-dated optionality on non-producing royalties converting as the uranium cycle turns.

Lens 2 · Supply Chain

Map the value chain, named stakeholders:

• Upstream operators (who actually mine the pounds UROY has claims on): Cameco + Orano Canada (McArthur River JV — Cameco 69.805% / Orano 30.195%; Cigar Lake JV — Cameco/Orano/others); Uranium Energy Corp (UEC) (Roughrider operator, and UROY's corporate parent-by-DNA); various US ISR developers (Anderson, Slick Rock, Reno Creek, Workman Creek operators).
• The uranium market UROY sells physical into: spot buyers via broker desks; the utility term-contract market (US/EU/Asian nuclear utilities); competing physical vehicles that set the marginal bid — Sprott Physical Uranium Trust (SPUT) (~74.9M lbs, ~US$6.1B, world's largest ) and Yellow Cake plc (LSE:YCA, ~21.68M lbs Sep-2025 ).
• End demand: nuclear utilities and, increasingly, hyperscalers procuring nuclear for data centers (Microsoft–Three Mile Island restart, Amazon–Talen/Susquehanna).
• Chokepoints / single-source dependencies: (i) UROY's producing cash flow is a single-mine dependency on McArthur River (via a royalty-in-kind); (ii) the global supply chain is dangerously concentrated — Kazakhstan = 43% of mine output, Kazatomprom the swing producer; (iii) the US ban on Russian uranium imports (HR 1042) removes ~20% of US fuel supply, tightening Western availability. UROY benefits from this tightness (its inventory marks up) but has no operational control over any of it — it is a pure price/optionality taker. This lens is generic-proof: the actual named counterparties are Cameco, Orano, UEC, SPUT, Yellow Cake, Kazatomprom.

Lens 3 · Competitive Advantages (moats)

Real but shallow.

• Scarcity / first-mover: UROY is the only pure-play uranium royalty company on a major exchange — a genuine niche monopoly on the "royalty structure applied to uranium" idea, and a scarcity premium when generalist money wants uranium-royalty exposure.
• Two irreplaceable producing royalties: McArthur River + Cigar Lake are Tier-1, lowest-cost, multi-decade assets you cannot buy a royalty on twice. That is a durable (if small) annuity of physical pounds.
• Physical uranium + zero debt (pre-Sweetwater): an unlevered, liquid, hard-asset balance sheet that can act counter-cyclically (buy pounds/royalties in downturns).

Why the moat is shallow: uranium royalties are not proprietary — anyone with capital (SPUT, Yellow Cake, Cameco itself, sovereign funds, or a well-capitalized entrant like… Sweetwater/Orion) can accumulate physical uranium or bid for royalties. There are no switching costs, no network effects, no IP. Bargaining power is weak: UROY needs the operators far more than they need it (it's a passive minority claim), and it competes with deeper-pocketed physical vehicles for the same pounds. Ground-truth on how thin the carried royalty book is: royalty interests sit at roughly C$15M of cost basis. The moat is "we got there first and hold the two good ones," not a defensible franchise.

Lens 4 · Segments

UROY does not report product/geographic segments in the conventional sense — its P&L is dominated by opportunistic physical-uranium sales, not recurring segment revenue. The honest way to "segment" this company is by balance-sheet asset composition:

Trend: cash exploded from C$12.9M (Apr-2025) → C$124.2M (Jan-2026) — funded by ATM equity issuance and physical-uranium sales (e.g. 350,000 lbs sold post-Apr-2025 at US$69.27/lb = US$24.2M ). Physical uranium fell C$217.5M → C$184.9M over the same window (sales + repricing). Revenue geography/product is not meaningful pre-Sweetwater; post-Sweetwater the real segmentation becomes uranium vs. soda-ash (trona) — and soda ash would dominate (~US$74M EBITDA vs UROY's near-zero royalty EBITDA). This is the single most important structural fact in the file.

---

Phase B — Measure performance

Lens 5 · Earnings Result

GAAP earnings are the wrong lens for this company and I will say so rather than over-interpret them. Reported results (CAD, IFRS):

Read it correctly: revenue swings ±200% because "revenue" is mostly proceeds from selling physical uranium, timed opportunistically — FY2024's C$42.7M was selling into the 2024 spot spike; FY2025's C$15.6M was a quieter sales year into a softer tape (spot fell from ~US$107 Feb-2024 to ~US$63 Mar-2025 ). The FY2025 net loss is an operating/overhead + soft-sales loss, not a demand-signal about a franchise. Balance sheet is pristine: near-zero debt (C$0.17M), equity ~C$381M, current ratio ~200x. There is no consensus to "beat/miss" in any meaningful way — sell-side coverage is thin and models NAV, not EPS.

Market reaction / what's actually priced: the stock is ~US$2.82 (July 6 2026 close), market cap ~US$415M, ~146.48M shares. It is down ~47% from its 52-wk high (~US$5.29–5.52) and — critically — trades ~22% below the US$3.64 per-share value the Sweetwater deal was struck at. Translation: the market is discounting deal risk and/or judging the transformation dilutive, not celebrating it.

Lens 6 · Earnings Calls (sentiment trend)

No transcripts on disk (transcripts/ empty); FPIs file 6-Ks and hold light calls, so the sentiment signal is thinner than for a US operating company. From management commentary and the deal cadence, the tone has shifted decisively over the last ~12 months from "patient accumulator of uranium optionality" to "transformational consolidator." Recurring themes now: "leading royalty platform," "Wyoming's largest landowner," "diversification," "cash-flowing." Things they've stopped emphasizing: the pure-play uranium identity and the zero-debt balance sheet (both of which the Sweetwater deal ends). The most information-dense management action is not a phrase but a decision: electing to redomicile, lever up, and hand voting control to Orion/OTPP — a management team explicitly telling you it would rather run a big diversified platform than a small pure uranium vehicle. Read that as ambition + a bet that scale/cash flow re-rates the equity — but also as founders comfortable ceding control. Sentiment is best labeled `` and structural, not tonal.

Lens 7 · Comps

Two comp sets, because UROY straddles both and fits neither cleanly.

A) Precious/hard-asset royalty companies (the model UROY imitates; the model the combined company becomes):

Royalty companies trade 1.5–2.0x NAV vs miners' 0.7–0.9x — the premium UROY's promoters are chasing.

B) Physical-uranium vehicles (what UROY's biggest asset actually is):

• Sprott Physical Uranium Trust (SPUT): ~74.9M lbs, ~US$6.13B (Jan-2026); traded ~7–8% discount to NAV mid-2025.
• Yellow Cake plc (LSE:YCA): ~21.68M lbs (Sep-2025); pure physical hold.

UROY's own valuation: IFRS book equity ~C$381M ≈ US$274M → book value ~US$1.87/share. Stock US$2.82 → ~1.5x book. But book understates NAV twice: (i) physical uranium is carried at ~US$57/lb vs ~US$85 spot — an embedded ~US$65M (~US$0.45/sh) gain not fully in book equity; (ii) royalty options at ~C$15M cost. Adjust for those and the stock is closer to ~1.1–1.3x a fuller NAV — a modest premium to hard NAV for the royalty optionality and pure-play scarcity, narrower than the 1.5–2.0x scaled royalty comps but without their producing cash flow. That gap is exactly what the Sweetwater deal is meant to close.

Lens 8 · Stock-Price Catalysts (what actually moves UROY >5%)

Pattern over ~5 years, ``:

• Uranium spot price is the dominant driver — UROY is a levered proxy on the physical (its NAV is ~half physical uranium). The 2023–24 bull run (to US$107 Feb-2024) lifted it; the 2024–25 drawdown to US$63 sank it; the early-2026 re-spike >US$100 lifted it again. Spot US$85.55 on July 8 2026.
• SPUT buying — fund physical purchases tighten spot and move the whole complex.
• Supply shocks — Kazatomprom guidance cuts (2025 output cut ~20% below prior expectations; 2026 reduction signaled) and the Russian-import ban are the biggest up-catalysts.
• Company-specific, 2026: the April 16 2026 Sweetwater announcement is the single largest idiosyncratic move — the stock has roughly halved from ~US$5.29–5.40 at announcement to ~US$2.82, i.e. a large negative idiosyncratic reaction layered on softer uranium. The July 20 2026 shareholder vote is the next binary.

What the pattern reveals: the market reacts to uranium price and supply headlines first, and to UROY's own capital-allocation choices second — and it did not like the Sweetwater choice, at least at the struck price.

---

Phase C — Judge people & books

Lens 9 · Management

The single most important qualitative fact: UROY is an "Adnani-constellation" company.

• Amir Adnani — Chairman (not independent). Founder/President/CEO of Uranium Energy Corp (UEC) since 2005; founder & Co-Chairman of GoldMining Inc.; founder of Gold Royalty Corp (director 2020–23). Serves UROY via a consulting agreement with Amir Adnani Corp (C$10K/mo + GST). A serial promoter/vehicle-builder — genuinely early and right on the uranium thesis, and skilled at capital formation; also the archetype of a founder who runs many related public shells that transact with one another.
• Scott Melbye — President & CEO. Simultaneously EVP of UEC; ~40-year uranium-market veteran (ex-Cameco, ex-Uranium Participation). Serves UROY via Castle Rock Uranium LLC (US$10K/mo). Deep industry credibility and Rolodex.
• CFO — Josephine Man; Audit Committee — Ken Robertson (Chair, designated financial expert), Donna Wichers, Neil Gregson, Vina Patel.
• Track record: Adnani/Melbye were early and correct on the 2020–24 uranium re-rate; UEC compounded hard. UROY itself IPO'd the "uranium royalty" concept and assembled the McArthur/Cigar Lake royalties (2021) — a real, well-timed coup.
• Skin in the game / capital allocation: management fees are small; insider ownership exists but the bigger tell is dilution — persistent ATM issuance (133.6M → 146.5M shares) and now a 223M-share deal issuance. Management has consistently chosen scale via equity over per-share discipline. The Sweetwater deal is the apotheosis: it hands 59% voting control to Orion + OTPP in exchange for scale/cash flow.
• Red flags (governance): related-party consulting agreements; a royalty on UEC's own Roughrider project (paying a related party); UEC providing a US$40M escrowed investment to backstop the Sweetwater deal — i.e. the affiliate funding the affiliate. This is not alleged wrongdoing; it is a structurally conflicted, promoter-run governance model. Judge accordingly.

Lens 10 · Forensic Red Flags

Act as forensic analyst. Accounting posture is, on the evidence, clean but opaque-by-structure:

• Revenue quality: low. "Revenue" commingles recurring royalty income with discretionary physical-uranium sales, so the top line is management-timed, not demand-driven. Anyone modeling UROY on revenue growth is being misled by the label (Lens 5).
• Physical uranium carrying value: ~C$184.9M for 2.33M lbs ≈ ~US$57/lb vs ~US$85 spot — consistent with cost-basis (IAS 2 lower-of-cost/NRV) inventory accounting, which means gains are recognized only on sale, and book equity understates mark-to-market NAV. (I could not confirm the exact IAS treatment from the on-disk 40-F cover — the accounting policies sit in un-ingested Exhibit 99.3 — so this is labeled an interpretation, not a sourced policy statement.) Net effect is conservative, not aggressive.
• Investments (FVTPL): ~C$58M of uranium-junior stakes marked to fair value — a genuine source of non-cash P&L volatility and the likely swing factor behind the FY2025 loss.
• Controls: management concluded ICFR effective as at Apr 30 2025; no auditor attestation because UROY is an emerging-growth company exempt under the JOBS Act (SOX 404(b)). Auditor PwC LLP (Vancouver), Firm ID 271. Standard EGC limitation — watch it lapse as the company scales past EGC thresholds (and it will, post-Sweetwater).
• Cash vs earnings: operating cash flow is structurally weak/negative in soft years (the company funds itself with equity + uranium sales, not royalty cash) — the FY2025 loss plus the C$100M+ cash build came from financing/asset sales, not operations. Flagged, not damning, for a NAV vehicle — but it becomes damning if the Sweetwater cash flow doesn't arrive.

Regulatory findings:

• SEC Litigation Releases: none naming Uranium Royalty (EDGAR EFTS, LR, 2021-07-10→2026-07-10).
• AAERs: none.
• Non-SEC (FTC/DOJ/etc.): web search surfaced no material enforcement actions, consent decrees, fines or penalties against Uranium Royalty Corp.
• 40-F Item on legal proceedings: the 40-F incorporates risk factors by reference to the AIF (Exhibit 99.1) and discloses no material pending litigation on the cover shell; standard forward-looking/mining risk factors only.
• Verdict: No material regulatory or legal findings — verified via SEC EDGAR EFTS (LR, AAER), web search, and the 40-F as of 2026-07-10. The risk here is governance/related-party structure, not enforcement history.

---

Phase D — Project & stress-test

Lens 11 · Forward Projection

A point EPS estimate would be a fabrication and I decline to publish one — GAAP EPS is dominated by lumpy physical-uranium sales + FVTPL marks + a company that is about to change shape entirely. Per provenance discipline, the honest projection is NAV-scenario, not EPS, with arithmetic shown. (No forecast.ts logged — watchlist mode + no committed base case; the July-20 vote makes any point forecast premature.)

Standalone UROY NAV sensitivity to uranium price, anchoring on 2.33M lbs physical + ~C$124M cash + ~C$58M investments + royalty optionality:

• Physical uranium P&L exposure ≈ US$2.33M per US$1/lb move.
• Bear (U3O8 → US$65): physical ~US$151M; hard NAV/sh ≈ US$1.9–2.1.
• Base (U3O8 ~US$85, today): physical ~US$198M; hard NAV/sh ≈ US$2.3–2.6 + royalty option value — roughly at today's ~US$2.82 price.
• Bull (U3O8 → US$120): physical ~US$280M; hard NAV/sh ≈ US$2.9–3.3 + richer royalty options.

Pro-forma (if Sweetwater closes):

• Shares: ~146.5M + 223.25M new ≈ ~370M (before the US$40M placement) — a ~152% increase.
• Adds Sweetwater's ~US$74M adjusted EBITDA (soda ash, real & recurring) and US$625M of debt; combined EV ~US$2.4B.
• Implied combined EV/EBITDA on current soda-ash EBITDA alone ≈ ~32x — rich versus the 15.8–28.9x royalty-sector P/CF range, so bulls must underwrite Sweetwater's +60% soda-ash capacity growth, the uranium optionality, and the 4.5M-acre land bank to justify the mark. At the US$3.64 deemed deal price, the combined equity is ~US$1.35B. The three-year path is therefore binary on the July 20 vote, then a soda-ash cash-flow + uranium-optionality story, not a uranium-EPS story.

Lens 12 · Bull vs Bear

Bull case. Uranium's structural deficit is real and multi-year — WNA sees demand +40% by 2035, ~15 reactors online in 2026, AI/data-center load (data-center power ~triples by 2030 per S&P), SMRs (up to 25 GW planned), reactor restarts, the Russian-import ban and Kazatomprom cuts all tightening supply. UROY is a levered, liquid proxy on the physical, holds two irreplaceable Tier-1 producing royalties, and — via Sweetwater — cures its one fatal flaw (no recurring cash flow) by bolting on ~US$74M of soda-ash EBITDA, a 4.5M-acre Wyoming land bank (renewables/lithium/uranium optionality), and blue-chip anchor owners (Orion, OTPP) who bring capital and discipline. If the vote passes and uranium grinds higher, a re-rated, cash-flowing, diversified royalty platform at a discount to the US$3.64 deal mark is cheap. One analyst carries a Buy, C$6.25 (~US$4.55) target.

Bear case (permanent-impairment risks). (1) Identity destruction / mis-sold thesis — investors bought "pure-play uranium royalty"; they are being handed a soda-ash company where trona, not uranium, is most of the EBITDA. The scarcity premium that justified UROY's existence evaporates. (2) Control transfer + dilution — 223M new shares (~152% dilution) and 59% voting control to Orion/OTPP; minority holders become passengers in a vehicle steered by a PE seller who is monetizing into your stock. (3) Leverage — zero-debt becomes US$625M debt; the counter-cyclical optionality of the old balance sheet is gone. Pre-mortem (18 months out, thesis broke): the vote passed at a rich EV/EBITDA into a softening uranium tape; soda-ash pricing/volumes disappointed; the US$625M debt + integration swamped the thin uranium royalty cash flow; Orion began distributing/selling; the stock de-rated toward hard NAV and sat there — a sub-scale, over-levered, orphaned hybrid that is neither a clean uranium play nor a scaled royalty. Contrarian view the market may be missing (either direction): the bearish surprise is that "diversification" here is really de-worsification of a pure thesis at a full price; the bullish surprise is that soda ash (glass + Li-ion batteries) is itself a quiet critical-materials growth royalty and Orion/OTPP are validating, not exiting.

Lens 13 · Devil's Advocate (short-seller)

Dismantling the bull case:

• Where's the cash flow? Standalone, UROY's recurring royalty cash flow is negligible — a GORR on <0.1% of one mine. The "earnings" are physical-uranium trading. You are paying ~1.5x book for a levered uranium ETF with a promoter overlay — and SPUT/Yellow Cake give cleaner physical exposure, at times at a discount to NAV.
• Concentration & related parties: producing cash flow concentrated in McArthur River; a royalty paid by UEC's own Roughrider; management seconded from UEC; UEC funding the Sweetwater deal (US$40M). This is a web of affiliated interests around a chairman who runs a stable of public vehicles (UEC, GoldMining, Gold Royalty Corp) — and Gold Royalty Corp's own filings flag exactly this "acquired the majority of its royalties from its parent… related-party… conflicts of interest… no assurance terms were arm's-length" pattern. The most dangerous competitor bulls underestimate isn't a rival — it's the misalignment inside the cap table.
• The deal is the tell: a promoter selling ~152% dilution and voting control to a PE fund at a price the market immediately marked down ~47% is not a vote of confidence — it's an exit-liquidity structure for Orion dressed as a "leading platform." If the assets were as good as claimed, why cede control?
• Valuation if growth disappoints 20–30%: on soft uranium + a soda-ash volume/price miss, combined EBITDA slips toward ~US$50–55M against US$625M debt and ~US$2.4B EV — an over-levered mid-cap trading well through the deal mark toward hard NAV (~US$2 or below). The single scenario that permanently impairs: vote passes at the top of the uranium cycle; uranium mean-reverts to the US$50s while soda-ash disappoints and the debt bites — permanent per-share value destruction locked in by the dilution.

Lens 14 · Management Questions (ordered by information value)

1. Why cede 59% voting control to Orion/OTPP now — what did you conclude about UROY's standalone cost of capital that made a control transfer the best option for existing holders?
2. Since the market marked the stock ~22% below the US$3.64 deal price, what is your response to holders who see the terms as dilutive/anchored to Orion's exit rather than UROY's intrinsic value?
3. Post-close, what is the pro-forma uranium vs soda-ash EBITDA split, and how do you defend keeping "Uranium Royalty" as the name?
4. What are Orion's and OTPP's lock-ups and distribution intentions — what stops them selling into the float once tradeable?
5. Sweetwater's ~US$74M EBITDA: what are the soda-ash price and volume assumptions, contract structures (take-or-pay?), and the realistic timeline/capex behind the "+60% capacity"?
6. Terms of the US$625M debt — maturity, rate, covenants — and pro-forma net-debt/EBITDA at strip uranium and soda-ash prices?
7. What is the source of the US$330M cash consideration given only ~C$124M on hand — new debt, a raise, or asset sales, and at what dilution?
8. On related-party governance: will the UEC secondments, the UEC-operated Roughrider royalty, and UEC's US$40M deal investment persist post-close, and how is the independent board ring-fencing these?
9. How do you carry physical uranium (cost vs fair value), and will you publish a standardized NAV-per-share so holders can track premium/discount like SPUT/Yellow Cake?
10. Redomicile to a US parent + Nasdaq — will the TSX listing survive, and what's the tax/withholding impact for existing Canadian holders exchanging 1:1?
11. If uranium falls to the US$50s, what is the plan for the physical inventory and the non-producing royalty book — hold, monetize, or write down?
12. Which of the 20 royalties do you expect to turn producing within 3–5 years, and what incremental cash flow do they add?
13. What is capital-allocation priority post-close — debt paydown, buybacks (given the discount), uranium accumulation, or new royalty M&A?
14. What KPIs should holders judge management on 1, 2, 3 years out now that EPS is meaningless?
15. What would have to be true for you to walk away from Sweetwater, and is there a break-fee?

---